Viewing data from:

VENLAFAXINE HYDROCHLORIDE

ANDA

VENLAFAXINE HYDROCHLORIDE | A091123 | ORBION PHARMACEUTICALS PRIVATE LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: EFFEXOR XR(TE code: AB)

API Supply Chain30 active DMFs16 inactive

27 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED LTDVENLAFAXINE HYDROCHLORIDE

DMF 89711991

TAPI NL BVVENLAFAXINE HYDROCHLORIDE

DMF 162812002

CHONGQING CARELIFE PHARMACEUTICAL CO LTDVENLAFAXINE HYDROCHLORIDE USP (NON-STERILE BULK DRUG SUBSTANCE)

DMF 169192003

MOEHS IBERICA SLVENLAFAXINE HYDROCHLORIDE

DMF 172582004

MATRIX PHARMACORP PRIVATE LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 175252004

ZYDUS LIFESCIENCES LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 182112005

LUPIN LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 182702005

DR REDDYS LABORATORIES LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 183472005

TORRENT PHARMACEUTICALS LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 187152005

ALEMBIC PHARMACEUTICALS LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 187342005

CADILA PHARMACEUTICALS LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 193862005

SUN PHARMACEUTICAL INDUSTRIES LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 197992006

ORBION PHARMACEUTICALS PRIVATE LTDVENLAFAXINE HYDROCHLORIDE

DMF 209632007

ZHEJIANG RAYBOW PHARMACEUTICAL CO LTDVENLAFAXINE HYDROCHLORIDE

DMF 211952007

APOTEX PHARMACHEM INDIA PVT LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 213772008

AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)VENLAFAXINE HYDROCHLORIDE USP

DMF 214392008

SOLARA ACTIVE PHARMA SCIENCES LTDVENLAFAXINE HYDROCHLORIDE

DMF 218242008

MEGAFINE PHARMA P LTDVENLAFAXINE HYDROCHLORIDE

DMF 226792009

HIKAL LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 229562009

MEGAFINE PHARMA P LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 231022009

ZHEJIANG RAYBOW PHARMACEUTICAL CO LTDVENLAFAXINE HYDROCHLORIDE CRYSTALLINE FORM B

DMF 261632012

AARTI PHARMALABS LTDVENLAFAXINE HYDROCHLORIDE POLYMORPH B

DMF 284332014

CADILA PHARMACEUTICALS LTDVENLAFAXINE HYDROCHLORIDE USP (PROCESS-2)

DMF 297182015

IPCA LABORATORIES LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 314972017

COHANCE LIFESCIENCES LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 345072020

AMOLI ORGANICS PVT LTDVENLAFAXINE HYDROCHLORIDE (FORM-B)

DMF 361402021

HETERO DRUGS LTDVENLAFAXINE HYDROCHLORIDE

DMF 365002021

ATUL BIOSCIENCE LTDVENLAFAXINE HYDROCHLORIDE

DMF 372862022

ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTDVENLAFAXINE HYDROCHLORIDE

DMF 377142022

MSN LIFE SCIENCES PRIVATE LTDVENLAFAXINE HYDROCHLORIDE USP

DMF 396712024

SIEGFRIED USA LLCInactiveVENLAFAXINE HYDROCHLORIDE

DMF 89671991

ZACH SYSTEM SAInactiveVENLAFAXINE HYDROCHLORIDE

DMF 123461997

UQUIFA MEXICO SA DE CVInactiveVENLAFAXINE HYDROCHLORIDE

DMF 161882002

ALEMBIC PHARMACEUTICALS LTDInactiveVENLAFAXINE HYDROCHLORIDE

DMF 165512003

GADOR SAInactiveVENLAFAXINE HYDROCHLORIDE

DMF 177972004

IND SWIFT LABORATORIES LTDInactiveVENLAFAXINE HYDROCHLORIDE

DMF 182012005

PCASInactiveVENLAFAXINE HYDROCHLORIDE

DMF 182462005

AMINO CHEMICALS LTDInactiveVENLAFAXINE HYDROCHLORIDE

DMF 188782005

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveVENLAFAXINE HYDROCHLORIDE

DMF 189832005

RANBAXY LABORATORIES LTDInactiveVENLAFAXINE HYDROCHLORIDE

DMF 200752006

CIPLA LTDInactiveVENLAFAXINE HYDROCHLORIDE FORM B

DMF 201592007

ALEMBIC PHARMACEUTICALS LTDInactiveVENLAFAXINE HYDROCHLORIDE

DMF 203062007

PHARMATHEN INDUSTRIAL SAInactiveVENLAFAXINE HYDROCHLORIDE

DMF 213712008

NOVUS FINE CHEMICALS LLCInactiveVENLAFAXINE HYDROCHLORIDE

DMF 220222008

CADILA HEALTHCARE LTDInactiveVENLAFAXINE HYDROCHLORIDE PH EUR

DMF 226902009

ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTDInactiveVENLAFAXINE HYDROCHLORIDE API

DMF 243492010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 37.5MG BASE

0 patents0 exclusivities▴

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Jul 11, 2011

No patent or exclusivity listings for this strength.

#002 — EQ 75MG BASE

0 patents0 exclusivities▾

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Jul 11, 2011

#003 — EQ 150MG BASE

0 patents0 exclusivities▾

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Jul 11, 2011